Robert J. More, Director at Vir Biotechnology, Inc. (VIR), sold 22,450 shares at $45.23 ($1.0M) on 2021-07-01, disclosed to the SEC on 2021-07-06.
Open-market sale of $1.0M VIR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.31 | 4,794 | $212K | 21.1% |
| 2 | $44.31 | 4,794 | $212K | 21.1% |
| 3 | $45.23 | 5,986 | $271K | 26.9% |
| 4 | $45.23 | 5,986 | $271K | 26.9% |
| 5 | $46.22 | 890 | $41K | 4.1% |
| Total | $44.88 avg | 22,450 |
| $1.0M |
| 100% |
| Filing → |
| TYRA | BUY | 2021-09-17 | $2.5M | — | Filing → |
| VIR | SELL | 2021-08-02 | $859K | — | Filing → |
| VIR | SELL | 2021-07-19 | $830K | — | Filing → |